Klor-Con Powder for oral solution is available as packets that contain 1.5g of potassium chloride (supplying potassium 20mEq and chloride 20mEq) in 30- and 100-count cartons. Upsher-Smith announced ...

June 24, 2009 — On June 17, the US Food and Drug Administration (FDA) approved diclofenac potassium for oral solution (Cambia, marketed by Kowa Pharmaceuticals America, Inc, under license from Applied ...

BEDMINSTER, N.J.--(BUSINESS WIRE)--Nautilus Neurosciences, Inc. has completed a transaction for the sale of the U.S. and Canadian rights to CAMBIA® (diclofenac potassium for oral solution) to Depomed, ...

Strides Pharma Science Limited (Strides) has announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Limited, Singapore, has received approval for Potassium Chloride for Oral ...

Depomed to host investor conference call today at 5:00 p.m. EST, 2:00 p.m. PST "CAMBIA, our third product acquisition in 18 months, is a unique and fast acting treatment for migraine with long-term ...

DUBLIN, Sept. 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced new real-world evidence and Phase 4 data reinforcing the value of Xywav® (calcium, magnesium, potassium, ...

MAPLE GROVE, Minn., Nov. 28, 2017 /PRNewswire/ -- Upsher-Smith Laboratories, LLC. (Upsher-Smith) today announced the launch of KLOR-CON ® Powder (Potassium Chloride) for oral solution, 20 mEq. The ...

The approved product is bioequivalent to the reference listed drug Potassium Chloride Oral Solution of Genus Lifesciences, Inc. Advisory Alert: It has come to our attention that certain individuals ...

Drug firm Strides Pharma Science on Monday said its step-down subsidiary, Strides Pharma Global Pte Ltd, has received approval from the US health regulator for potassium chloride for oral solution, ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

New Delhi, Aug 31 (PTI) Drug firm Lupin today said it has received approval from the US health regulator to sell its potassium chloride oral solution used for treatment of low potassium levels in the ...